Moberg Pharma AB (OSTO:MOB) Price-to-Operating-Cash-Flow : (As of Sep. 22, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Price-to-Operating-Cash-Flow?

As of today (2024-09-22), Moberg Pharma AB's share price is kr11.21. Moberg Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was kr-0.87. Hence, Moberg Pharma AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Moberg Pharma AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Moberg Pharma AB's highest Price-to-Operating-Cash-Flow Ratio was 864.47. The lowest was 5.15. And the median was 22.17.

OSTO:MOB's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.64
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Moberg Pharma AB's Cash Flow from Operations per share for the three months ended in Jun. 2024 was kr-0.32. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was kr-0.87.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 54.80% per year.

During the past 13 years, Moberg Pharma AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.70% per year. The lowest was -64.10% per year. And the median was 32.30% per year.

Moberg Pharma AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Moberg Pharma AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Price-to-Operating-Cash-Flow Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

10.16

Moberg Pharma AB Quarterly Data
	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Moberg Pharma AB's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Price-to-Operating-Cash-Flow falls into.

Moberg Pharma AB Price-to-Operating-Cash-Flow Calculation

Moberg Pharma AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	11.21	/	-0.873
	=

Moberg Pharma AB's Share Price of today is kr11.21.
Moberg Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.87.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Moberg Pharma AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MOBs:UK MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.